The protective effects of bexarotene against advanced glycation end-product (AGE)-induced degradation of articular extracellular matrix (ECM)

References

• Osteoarthritis. Centers for Disease Control and Prevention Centers for Disease Control and Prevention. 2018.
   Google Scholar
• Arden N, Nevitt MC. Osteoarthritis: epidemiology. Best Pract Res Clin Rheumatol. 2006;20(1):3–25.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Jordan JM. Epidemiology of osteoarthritis. Clin Geriatr Med. 2010;26(3):355–369.
   PubMed Web of Science ®Google Scholar
• Johnson VL, Hunter DJ. The epidemiology of osteoarthritis. Best Pract Res Clin Rheumatol. 2014;28(1):5–15.
   PubMed Web of Science ®Google Scholar
• Aigner T, Haag J, Martin J, et al. Osteoarthritis: aging of matrix and cells-going for a remedy. Curr Drug Targets. 2007;8(2):325–331.
   PubMed Web of Science ®Google Scholar
• Loeser RF, Collins JA, Diekman BO. Ageing and the pathogenesis of osteoarthritis. Nat Rev Rheumatol. 2016;12(7):412.
   PubMed Web of Science ®Google Scholar
• Singh R, Barden A, Mori T, et al. Advanced glycation end-products: a review. Diabetologia. 2001;44(2):129–146.
   PubMed Web of Science ®Google Scholar
• Schett G, Kleyer A, Perricone C, et al. Diabetes is an independent predictor for severe osteoarthritis: results from a longitudinal cohort study. Diabetes Care. 2013;36(2):403–409.
   PubMed Web of Science ®Google Scholar
• Nonaka K, Kajiura Y, Bando M, et al. Advanced glycation end-products increase IL-6 and ICAM-1 expression via RAGE, MAPK and NF-κB pathways in human gingival fibroblasts. J Periodont Res. 2018;53(3):334–344.
   PubMed Web of Science ®Google Scholar
• Nowotny K, Jung T, Höhn A, et al. Advanced glycation end products and oxidative stress in type 2 diabetes mellitus. Biomolecules. 2015;5(1):194–222.
   PubMed Web of Science ®Google Scholar
• van Zoelen MA, Yang H, Florquin S, et al. Role of Toll-like receptors 2 and 4, and the receptor for advanced glycation end products in high-mobility group box 1–induced inflammation in vivo. Shock. 2009;31(3):280.
   PubMed Web of Science ®Google Scholar
• Chen YJ, Chan DC, Chiang CK, et al. Advanced glycation end‐products induced VEGF production and inflammatory responses in human synoviocytes via RAGE-NF-κB pathway activation. J Orthop Res. 2016;34(5):791–800.
   PubMed Web of Science ®Google Scholar
• Lin SS, Yuan LJ, Niu CC, et al. Hyperbaric oxygen inhibits the HMGB1/RAGE signaling pathway by upregulating Mir-107 expression in human osteoarthritic chondrocytes. Osteoarthr Cartilage. 2019;27(9):1372.
   PubMed Web of Science ®Google Scholar
• Nah SS, Choi IY, Yoo B, et al. Advanced glycation end products increases matrix metalloproteinase-1,-3, and-13, and TNF-α in human osteoarthritic chondrocytes. FEBS Lett. 2007;581(9):1928–1932.
   PubMed Web of Science ®Google Scholar
• Akkiraju H, Nohe A. Role of chondrocytes in cartilage formation, progression of osteoarthritis and cartilage regeneration. J Dev Biol . 2015;3(4):177–192.
   PubMed Web of Science ®Google Scholar
• Verzijl N, DeGroot J, Thorpe SR, et al. Effect of collagen turnover on the accumulation of advanced glycation end products. J Biol Chem. 2000;275(50):39027–39031.
   PubMed Web of Science ®Google Scholar
• Farol LT, Hymes KB. Bexarotene: a clinical review. Expert Rev Anticancer Ther. 2004;4(2):180–188.
   PubMedGoogle Scholar
• Hurst RE. Bexarotene ligand pharmaceuticals. Curr Opin Investig Drugs. 2000;1(4):514–523.
   PubMedGoogle Scholar
• Abbott RA, Whittaker SJ, Morris SL, et al. Bexarotene therapy for mycosis fungoides and Sézary syndrome. Br J Dermatol. 2009;160(6):1299–1307.
   PubMed Web of Science ®Google Scholar
• Bhuyan AA, Bissinger R, Cao H, et al. Triggering of suicidal erythrocyte death by bexarotene. Cell Physiol Biochem. 2016;40(5):1239–1251.
   PubMedGoogle Scholar
• Medarametla L, Casali BT, Landreth GE. Effects of bexarotene on neuroinflammation in an ad mouse model. Ohio J Sci. 2017;117(1):A18.
   Google Scholar
• O'hare E, Jeggo R, Kim EM, et al. Lack of support for bexarotene as a treatment for Alzheimer's disease. Neuropharmacology. 2016;100:124–130.
   PubMed Web of Science ®Google Scholar
• Faria RX, Gonzaga DTG, Pacheco PAF, et al. Searching for new drugs for Chagas diseases: triazole analogs display high in vitro activity against Trypanosoma cruzi and low toxicity toward mammalian cells. J Bioenerg Biomembr. 2018;50(2):81–91.
   PubMed Web of Science ®Google Scholar
• Eftekhari A, Ahmadian E, Panahi-Azar V, et al. Hepatoprotective and free radical scavenging actions of quercetin nanoparticles on aflatoxin B1-induced liver damage: in vitro/in vivo studies. Artif Cells Nanomed Biotechnol. 2018;46(2):411–420.
   PubMed Web of Science ®Google Scholar
• Dechandt CRP, Zuccolotto-Dos-Reis FH, Teodoro BG, et al. Triacsin C reduces lipid droplet formation and induces mitochondrial biogenesis in primary rat hepatocytes. J Bioenerg Biomembr. 2017;49(5):399–411.
   PubMed Web of Science ®Google Scholar
• Shajari N, Davudian S, Kazemi T, et al. Silencing of BACH1 inhibits invasion and migration of prostate cancer cells by altering metastasis-related gene expression. Artif Cells Nanomed Biotechnol. 2018;46(7):1495–1504.
   PubMed Web of Science ®Google Scholar
• Amini Y, Moradi B, Fasihi-Ramandi M. Aluminum hydroxide nanoparticles show strong activity to stimulate Th-1 immune response against tuberculosis. Artif Cells Nanomed Biotechnol. 2017;45(7):1331–1335.
   PubMed Web of Science ®Google Scholar
• Zhang P, Ma J, Gao J, et al. Downregulation of monocarboxylate transporter 1 inhibits the invasion and migration through suppression of the PI3K/Akt signaling pathway in human nasopharyngeal carcinoma cells. J Bioenerg Biomembr. 2018;50(4):271–281.
   PubMed Web of Science ®Google Scholar
• Jolly AJ, Wild CP, Hardie LJ. Sodium deoxycholate causes nitric oxide mediated DNA damage in oesophageal cells. Free Radic Res. 2009;43(3):234–240.
   PubMed Web of Science ®Google Scholar
• Guimarães EL, Empsen C, Geerts A, et al. Advanced glycation end products induce production of reactive oxygen species via the activation of NADPH oxidase in murine hepatic stellate cells. J Hepatol. 2010;52(3):389–397.
   PubMed Web of Science ®Google Scholar
• Yamagishi SI, Matsui T. Advanced glycation end products, oxidative stress and diabetic nephropathy. Oxid Med Cell Longev. 2010;3(2):101–108.
   PubMed Web of Science ®Google Scholar
• Yamagishi SI, Ueda S, Matsui T, et al. Role of advanced glycation end products (AGEs) and oxidative stress in diabetic retinopathy. Curr Pharm Des. 2008;14(10):962–968.
   PubMed Web of Science ®Google Scholar
• Huang CY, Hung LF, Liang CC, et al. COX-2 and iNOS are critical in advanced glycation end product-activated chondrocytes in vitro. Eur J Clin Invest. 2009;39(5):417–428.
   PubMed Web of Science ®Google Scholar
• Lepetsos P, Papavassiliou AG. ROS/oxidative stress signaling in osteoarthritis. Biochim Biophys Acta. 2016;1862(4):576–591.
   PubMed Web of Science ®Google Scholar
• Qin R, Sun J, Wu J, et al. Pyrroloquinoline quinone prevents knee osteoarthritis by inhibiting oxidative stress and chondrocyte senescence. Am J Transl Res. 2019;11(3):1460–1472.
   PubMed Web of Science ®Google Scholar
• Shan P, Pu J, Yuan A, et al. RXR agonists inhibit oxidative stress-induced apoptosis in H9c2 rat ventricular cells. Biochem Bioph Res Co. 2008;375(4):628–633.
   PubMed Web of Science ®Google Scholar
• Chai D, Wang B, Shen L, et al. RXR agonists inhibit high-glucose-induced oxidative stress by repressing PKC activity in human endothelial cells. Free Radical Bio Med. 2008;44(7):1334–1347.
   PubMed Web of Science ®Google Scholar
• Laavola M, Leppänen T, Hämäläinen M, et al. IL-6 in osteoarthritis: effects of pine stilbenoids. Molecules. 2018;24(1):109.
   PubMed Web of Science ®Google Scholar
• Rasheed Z, Akhtar N, Haqqi TM. Advanced glycation end products induce the expression of interleukin-6 and interleukin-8 by receptor for advanced glycation end product-mediated activation of mitogen-activated protein kinases and nuclear factor-κB in human osteoarthritis chondrocytes. Rheumatology. 2011;50(5):838–851.
   PubMed Web of Science ®Google Scholar
• Zuo Y, Huang L, Enkhjargal B, et al. Activation of retinoid X receptor by bexarotene attenuates neuroinflammation via PPARγ/SIRT6/FoxO3a pathway after subarachnoid hemorrhage in rats. J Neuroinflammation. 2019;16(1):47.
   PubMedGoogle Scholar
• Xu YK, Ke Y, Wang B, et al. The role of MCP-1-CCR2 ligand-receptor axis in chondrocyte degradation and disease progress in knee osteoarthritis. Biol Res. 2015;48(1):64.
   PubMedGoogle Scholar
• Wang X, Guo Y, Wang C, et al. MicroRNA-142-3p inhibits chondrocyte apoptosis and inflammation in osteoarthritis by targeting HMGB1. Inflammation. 2016;39(5):1718–1728.
   PubMed Web of Science ®Google Scholar
• Aulin C, Palmblad K, Klareskog L, et al. Cartilage-saving effects of local HMGB1-neutralizing therapy in experimental osteoarthritis. Osteoarthr Cartilage. 2017;25:S435.
   PubMed Web of Science ®Google Scholar
• Sun MG, Ratneswaran A, Dupuis H, et al. Investigating the role of Retinoid X Receptor in cartilage development and homeostasis. Osteoarthr Cartilage. 2018;26:S98.
   Web of Science ®Google Scholar
• Cras A, Politis B, Balitrand N, et al. Bexarotene via CBP/p300 induces suppression of NF-κB–dependent cell growth and invasion in thyroid cancer. Clin Cancer Res. 2012;18(2):442–453.
   PubMed Web of Science ®Google Scholar